カテゴリー： QYResearch, 世界

免疫性血小板減少薬の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Immune Thrombocytopenia Drugs Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18558）・商品コード：DATA909X18558
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：98
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、免疫性血小板減少薬の世界市場について調査・分析し、免疫性血小板減少薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（トロンボポエチン受容体作動薬（TPO-RA）、コルチコステロイド、静脈内免疫グロブリン（IVIG）、その他薬物）、用途別（バイオテクノロジー及び製薬会社、病院及び診断センター、学術機関及び研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の免疫性血小板減少薬市場動向
・主要企業別マーケットシェア
・免疫性血小板減少薬の種類別市場規模2014-2019
（トロンボポエチン受容体作動薬（TPO-RA）、コルチコステロイド、静脈内免疫グロブリン（IVIG）、その他薬物）
・免疫性血小板減少薬の用途別市場規模2014-2019
（バイオテクノロジー及び製薬会社、病院及び診断センター、学術機関及び研究機関）
・免疫性血小板減少薬の北米市場：主要企業・種類別/用途別市場規模
・免疫性血小板減少薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・免疫性血小板減少薬の中国市場：主要企業・種類別/用途別市場規模
・免疫性血小板減少薬の日本国内市場：主要企業・種類別/用途別市場規模
・免疫性血小板減少薬の東南アジア市場：主要企業・種類別/用途別市場規模
・免疫性血小板減少薬のインド市場：主要企業・種類別/用途別市場規模
・免疫性血小板減少薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Amgen Inc.、CSL Ltd.、Horizon Therapeutics Plc、Merck & Co., Inc.、Novartis AG、Rigel Pharmaceuticals Inc.）
・免疫性血小板減少薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Thrombocytopenia is a condition characterized by abnormally low levels of thrombocytes, also known as platelets, in the blood.End-users prefer biosimilars over biologics because of their low cost. The low cost of biosimilars can be attributed to the fewer number of clinical trials required for approval. The upcoming expiration of patents in the immune thrombocytopenia drugs market will fuel the development of biosimilars for those products. For instance, the forthcoming expiration of patents of Nplate (romiplostim) and rituximab has encouraged market vendors to develop their biosimilars. This will also create several opportunities for new vendors to enter the market. Hence, the growing popularity and development of biosimilars will augment the growth of the immune thrombocytopenia drugs market throughout the next five years.
In 2018, the global Immune Thrombocytopenia Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Immune Thrombocytopenia Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immune Thrombocytopenia Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Amgen Inc.
CSL Ltd.
Horizon Therapeutics Plc
Merck & Co., Inc.
Novartis AG
Rigel Pharmaceuticals Inc.
…

Market segment by Type, the product can be split into
Thrombopoietin Receptor Agonists (TPO-RAs)
Corticosteroids
Intravenous Immunoglobins (IVIGs)
Other Drugs

Market segment by Application, split into
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Centers
Academic Institutes and Research Organizations

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Immune Thrombocytopenia Drugs status, future forecast, growth opportunity, key market and key players.
To present the Immune Thrombocytopenia Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Immune Thrombocytopenia Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Immune Thrombocytopenia Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Thrombopoietin Receptor Agonists (TPO-RAs)
1.4.3 Corticosteroids
1.4.4 Intravenous Immunoglobins (IVIGs)
1.4.5 Other Drugs
1.5 Market by Application
1.5.1 Global Immune Thrombocytopenia Drugs Market Share by Application (2019-2025)
1.5.2 Biotechnology and Pharmaceutical Companies
1.5.3 Hospitals and Diagnostic Centers
1.5.4 Academic Institutes and Research Organizations
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Immune Thrombocytopenia Drugs Market Size
2.2 Immune Thrombocytopenia Drugs Growth Trends by Regions
2.2.1 Immune Thrombocytopenia Drugs Market Size by Regions (2019-2025)
2.2.2 Immune Thrombocytopenia Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Immune Thrombocytopenia Drugs Market Size by by Players
3.1.1 Global Immune Thrombocytopenia Drugs Revenue by by Players (2014-2019)
3.1.2 Global Immune Thrombocytopenia Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Immune Thrombocytopenia Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Immune Thrombocytopenia Drugs Key Players Head office and Area Served
3.3 Key Players Immune Thrombocytopenia Drugs Product/Solution/Service
3.4 Date of Enter into Immune Thrombocytopenia Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Immune Thrombocytopenia Drugs Market Size by Type (2014-2019)
4.2 Global Immune Thrombocytopenia Drugs Market Size by Application (2014-2019)

5 North America
5.1 North America Immune Thrombocytopenia Drugs Market Size (2014-2019)
5.2 Immune Thrombocytopenia Drugs Key Players in North America
5.3 North America Immune Thrombocytopenia Drugs Market Size by Type
5.4 North America Immune Thrombocytopenia Drugs Market Size by Application

6 Europe
6.1 Europe Immune Thrombocytopenia Drugs Market Size (2014-2019)
6.2 Immune Thrombocytopenia Drugs Key Players in Europe
6.3 Europe Immune Thrombocytopenia Drugs Market Size by Type
6.4 Europe Immune Thrombocytopenia Drugs Market Size by Application

7 China
7.1 China Immune Thrombocytopenia Drugs Market Size (2014-2019)
7.2 Immune Thrombocytopenia Drugs Key Players in China
7.3 China Immune Thrombocytopenia Drugs Market Size by Type
7.4 China Immune Thrombocytopenia Drugs Market Size by Application

8 Japan
8.1 Japan Immune Thrombocytopenia Drugs Market Size (2014-2019)
8.2 Immune Thrombocytopenia Drugs Key Players in Japan
8.3 Japan Immune Thrombocytopenia Drugs Market Size by Type
8.4 Japan Immune Thrombocytopenia Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Immune Thrombocytopenia Drugs Market Size (2014-2019)
9.2 Immune Thrombocytopenia Drugs Key Players in Southeast Asia
9.3 Southeast Asia Immune Thrombocytopenia Drugs Market Size by Type
9.4 Southeast Asia Immune Thrombocytopenia Drugs Market Size by Application

10 India
10.1 India Immune Thrombocytopenia Drugs Market Size (2014-2019)
10.2 Immune Thrombocytopenia Drugs Key Players in India
10.3 India Immune Thrombocytopenia Drugs Market Size by Type
10.4 India Immune Thrombocytopenia Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Immune Thrombocytopenia Drugs Market Size (2014-2019)
11.2 Immune Thrombocytopenia Drugs Key Players in Central & South America
11.3 Central & South America Immune Thrombocytopenia Drugs Market Size by Type
11.4 Central & South America Immune Thrombocytopenia Drugs Market Size by Application

12 International Players Profiles
12.1 Amgen Inc.
12.1.1 Amgen Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Immune Thrombocytopenia Drugs Introduction
12.1.4 Amgen Inc. Revenue in Immune Thrombocytopenia Drugs Business (2014-2019))
12.1.5 Amgen Inc. Recent Development
12.2 CSL Ltd.
12.2.1 CSL Ltd. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Immune Thrombocytopenia Drugs Introduction
12.2.4 CSL Ltd. Revenue in Immune Thrombocytopenia Drugs Business (2014-2019)
12.2.5 CSL Ltd. Recent Development
12.3 Horizon Therapeutics Plc
12.3.1 Horizon Therapeutics Plc Company Details
12.3.2 Company Description and Business Overview
12.3.3 Immune Thrombocytopenia Drugs Introduction
12.3.4 Horizon Therapeutics Plc Revenue in Immune Thrombocytopenia Drugs Business (2014-2019)
12.3.5 Horizon Therapeutics Plc Recent Development
12.4 Merck & Co., Inc.
12.4.1 Merck & Co., Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Immune Thrombocytopenia Drugs Introduction
12.4.4 Merck & Co., Inc. Revenue in Immune Thrombocytopenia Drugs Business (2014-2019)
12.4.5 Merck & Co., Inc. Recent Development
12.5 Novartis AG
12.5.1 Novartis AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Immune Thrombocytopenia Drugs Introduction
12.5.4 Novartis AG Revenue in Immune Thrombocytopenia Drugs Business (2014-2019)
12.5.5 Novartis AG Recent Development
12.6 Rigel Pharmaceuticals Inc.
12.6.1 Rigel Pharmaceuticals Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Immune Thrombocytopenia Drugs Introduction
12.6.4 Rigel Pharmaceuticals Inc. Revenue in Immune Thrombocytopenia Drugs Business (2014-2019)
12.6.5 Rigel Pharmaceuticals Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Immune Thrombocytopenia Drugs Key Market Segments
Table Key Players Immune Thrombocytopenia Drugs Covered
Table Global Immune Thrombocytopenia Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Thrombopoietin Receptor Agonists (TPO-RAs) Figures
Table Key Players of Thrombopoietin Receptor Agonists (TPO-RAs)
Figuer Corticosteroids Figures
Table Key Players of Corticosteroids
Figuer Intravenous Immunoglobins (IVIGs) Figures
Table Key Players of Intravenous Immunoglobins (IVIGs)
Figuer Other Drugs Figures
Table Key Players of Other Drugs
Table Global Immune Thrombocytopenia Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Immune Thrombocytopenia Drugs Market Share by Application in 2018 & 2025
Figure Biotechnology and Pharmaceutical Companies Case Studies
Figure Hospitals and Diagnostic Centers Case Studies
Figure Academic Institutes and Research Organizations Case Studies
Figure Immune Thrombocytopenia Drugs Report Years Considered
Figure Global Immune Thrombocytopenia Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Immune Thrombocytopenia Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Immune Thrombocytopenia Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Immune Thrombocytopenia Drugs Market Share by Regions 2014-2019
Figure Global Immune Thrombocytopenia Drugs Market Share by Regions 2014-2019
Figure Global Immune Thrombocytopenia Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Immune Thrombocytopenia Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Immune Thrombocytopenia Drugs Market Share by by Players (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Market Share by by Players in 2018
Table Global Immune Thrombocytopenia Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Immune Thrombocytopenia Drugs Product/Solution/Service
Table Date of Enter into Immune Thrombocytopenia Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Immune Thrombocytopenia Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Immune Thrombocytopenia Drugs Market Size Share by Type (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Market Size Market Share by Type (2014-2019)
Table Global Immune Thrombocytopenia Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Immune Thrombocytopenia Drugs Market Size Share by Application (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Market Size Market Share by Application (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Market Share by Application in 2018
Figure North America Immune Thrombocytopenia Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Immune Thrombocytopenia Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Immune Thrombocytopenia Drugs Market Share (2018-2019)
Table North America Immune Thrombocytopenia Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Immune Thrombocytopenia Drugs Market Share by Type 2014-2019
Table North America Immune Thrombocytopenia Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Immune Thrombocytopenia Drugs Market Share by Application 2014-2019
Figure Europe Immune Thrombocytopenia Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Immune Thrombocytopenia Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Immune Thrombocytopenia Drugs Market Share (2018-2019)
Table Europe Immune Thrombocytopenia Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Immune Thrombocytopenia Drugs Market Share by Type 2014-2019
Table Europe Immune Thrombocytopenia Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Immune Thrombocytopenia Drugs Market Share by Application 2014-2019
Figure China Immune Thrombocytopenia Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Immune Thrombocytopenia Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Immune Thrombocytopenia Drugs Market Share (2018-2019)
Table China Immune Thrombocytopenia Drugs Market Size by Type 2014-2019 (Million US$)
Table China Immune Thrombocytopenia Drugs Market Share by Type 2014-2019
Table China Immune Thrombocytopenia Drugs Market Size by Application 2014-2019 (Million US$)
Table China Immune Thrombocytopenia Drugs Market Share by Application 2014-2019
Figure Japan Immune Thrombocytopenia Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Immune Thrombocytopenia Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Immune Thrombocytopenia Drugs Market Share (2018-2019)
Table Japan Immune Thrombocytopenia Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Immune Thrombocytopenia Drugs Market Share by Type 2014-2019
Table Japan Immune Thrombocytopenia Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Immune Thrombocytopenia Drugs Market Share by Application 2014-2019
Figure Southeast Asia Immune Thrombocytopenia Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Immune Thrombocytopenia Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Immune Thrombocytopenia Drugs Market Share (2018-2019)
Table Southeast Asia Immune Thrombocytopenia Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Immune Thrombocytopenia Drugs Market Share by Type 2014-2019
Table Southeast Asia Immune Thrombocytopenia Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Immune Thrombocytopenia Drugs Market Share by Application 2014-2019
Figure India Immune Thrombocytopenia Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Immune Thrombocytopenia Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Immune Thrombocytopenia Drugs Market Share (2018-2019)
Table India Immune Thrombocytopenia Drugs Market Size by Type 2014-2019 (Million US$)
Table India Immune Thrombocytopenia Drugs Market Share by Type 2014-2019
Table India Immune Thrombocytopenia Drugs Market Size by Application 2014-2019 (Million US$)
Table India Immune Thrombocytopenia Drugs Market Share by Application 2014-2019
Figure Central & South America Immune Thrombocytopenia Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Immune Thrombocytopenia Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Immune Thrombocytopenia Drugs Market Share (2018-2019)
Table Central & South America Immune Thrombocytopenia Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Immune Thrombocytopenia Drugs Market Share by Type 2014-2019
Table Central & South America Immune Thrombocytopenia Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Immune Thrombocytopenia Drugs Market Share by Application 2014-2019
Table Amgen Inc. Company Details
Table Amgen Inc. Revenue in Immune Thrombocytopenia Drugs Business 2014-2019 (Million US$)
Figure Amgen Inc. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2014-2019)
Table Amgen Inc. Recent Development
Table CSL Ltd. Company Details
Table CSL Ltd. Revenue in Immune Thrombocytopenia Drugs Business 2014-2019 (Million US$)
Figure CSL Ltd. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2014-2019)
Table CSL Ltd. Recent Development
Table Horizon Therapeutics Plc Company Details
Table Horizon Therapeutics Plc Revenue in Immune Thrombocytopenia Drugs Business 2014-2019 (Million US$)
Figure Horizon Therapeutics Plc Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2014-2019)
Table Horizon Therapeutics Plc Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Revenue in Immune Thrombocytopenia Drugs Business 2014-2019 (Million US$)
Figure Merck & Co., Inc. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2014-2019)
Table Merck & Co., Inc. Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Immune Thrombocytopenia Drugs Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2014-2019)
Table Novartis AG Recent Development
Table Rigel Pharmaceuticals Inc. Company Details
Table Rigel Pharmaceuticals Inc. Revenue in Immune Thrombocytopenia Drugs Business 2014-2019 (Million US$)
Figure Rigel Pharmaceuticals Inc. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2014-2019)
Table Rigel Pharmaceuticals Inc. Recent Development
Table Global Immune Thrombocytopenia Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Immune Thrombocytopenia Drugs Market Size Share by Regions (2019-2025)
Figure Global Immune Thrombocytopenia Drugs Market Size Share by Regions in 2025
Figure North America Immune Thrombocytopenia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Immune Thrombocytopenia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Immune Thrombocytopenia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Immune Thrombocytopenia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Immune Thrombocytopenia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Immune Thrombocytopenia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Immune Thrombocytopenia Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Immune Thrombocytopenia Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Immune Thrombocytopenia Drugs Market Size by Product (2019-2025)
Figure Global Immune Thrombocytopenia Drugs Market Size by Product in 2025
Table Global Immune Thrombocytopenia Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Immune Thrombocytopenia Drugs Market Size by Application (2019-2025)
Figure Global Immune Thrombocytopenia Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Amgen Inc.、CSL Ltd.、Horizon Therapeutics Plc、Merck & Co., Inc.、Novartis AG、Rigel Pharmaceuticals Inc.

★調査レポート[免疫性血小板減少薬の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18558)販売に関する免責事項を必ずご確認ください。
★調査レポート[免疫性血小板減少薬の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • そう痒治療薬の世界市場：規模・現状・予測2019-2025
    DATA909X18875 / QYResearch / 2019年11月25日 / ※当調査レポートでは、そう痒治療薬の世界市場について調査・分析し、そう痒治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（局所、経口、非経口）、用途別（血液性そう痒症、腫瘍性そう痒症、腎そう痒症、内分泌性掻そう痒症、胆汁うっ滞性そう痒症）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のそう痒治療薬市場動向 ・主要企業別マーケットシェア ・そう痒治療薬の種類別市場規模2014-2019 （局所、経口、非経口） ・そう痒治療薬の用途別市場規模2014-2019 （血液性そう痒症、腫瘍性そう痒症、腎そう痒症、内分泌性掻そう痒症、胆汁うっ滞性そう痒症） ・そう痒治療薬の北米市場：主要企業・種類別/用途別市場規模 ・そう痒治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Transdermal drug delivery systems are the most preferred methods of delivering pruritus drugs.The majority of the pruritus drugs are available in semi-solid topical dosage forms, such as lotions, gels, and creams, which are easier to apply, are less painful, and provides faster action than other forms of drug delivery methods. Moreover, transdermal drug delivery systems increase the bioavailability of active ingredients and prevent destructive hepatic first-pass metabolism. However, the delivery of small and lipophilic drugs is difficult through the method of drug development. In 2018, the global Pruritus Drugs market size was xx million US$ and it is expected to...
  • 気管支拡張薬の世界市場：規模・現状・予測2019-2025
    DATA909X18244 / QYResearch / 2019年11月25日 / ※当調査レポートでは、気管支拡張薬の世界市場について調査・分析し、気管支拡張薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗生物質、去痰薬、その他の薬物）、用途別（病院、研究所、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の気管支拡張薬市場動向 ・主要企業別マーケットシェア ・気管支拡張薬の種類別市場規模2014-2019 （抗生物質、去痰薬、その他の薬物） ・気管支拡張薬の用途別市場規模2014-2019 （病院、研究所、クリニック、その他） ・気管支拡張薬の北米市場：主要企業・種類別/用途別市場規模 ・気管支拡張薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bacteria in the lungs efficiently. The use of this probe will also help in identifying the exact causing agent of bronchiectasis. The high-resolution computed tomography (HRCT) scan has also emerged as a popular diagnostic technique for screening bronchiectasis and other respiratory diseases. Such advances in the diagnostics of respiratory diseases will enable pulmonologists and otolaryngologists...
  • 起立性低血圧治療薬の世界市場：規模・現状・予測2019-2025
    DATA909X18788 / QYResearch / 2019年11月25日 / ※当調査レポートでは、起立性低血圧治療薬の世界市場について調査・分析し、起立性低血圧治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ミドドリン、ノーテラ（ドロキシドパ）、フルドロコルチゾン、その他の薬物）、用途別（病院、医学研究所、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の起立性低血圧治療薬市場動向 ・主要企業別マーケットシェア ・起立性低血圧治療薬の種類別市場規模2014-2019 （ミドドリン、ノーテラ（ドロキシドパ）、フルドロコルチゾン、その他の薬物） ・起立性低血圧治療薬の用途別市場規模2014-2019 （病院、医学研究所、クリニック、その他） ・起立性低血圧治療薬の北米市場：主要企業・種類別/用途別市場規模 ・起立性低血圧治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...The increasing prevalence of chronic diseases will also contribute to the growth of the OH drugs market. Orthostatic hypotension is associated with various neurodegenerative diseases, cardiovascular diseases, and diabetes.Orthostatic hypotension is difficult to treat with single-drug therapy because orthostatic stress varies as per the circumstances during the day. Moreover, most of the OH drugs are used to improve postural symptoms, standing time, and function instead of achieving upright normotension that may cause supine hypertension. These factors have boosted the use of a combination of various drugs, such as midodrine and fludrocortisone, midodrine and pyridostigmine, or midodrine and octreotide, for the...
  • クリプトコッカス薬の世界市場：規模・現状・予測2019-2025
    DATA909X18352 / QYResearch / 2019年11月25日 / ※当調査レポートでは、クリプトコッカス薬の世界市場について調査・分析し、クリプトコッカス薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（アムホテリシンB、フルシトシン、フルコナゾール、その他）、用途別（病院薬局、小売薬局、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のクリプトコッカス薬市場動向 ・主要企業別マーケットシェア ・クリプトコッカス薬の種類別市場規模2014-2019 （アムホテリシンB、フルシトシン、フルコナゾール、その他） ・クリプトコッカス薬の用途別市場規模2014-2019 （病院薬局、小売薬局、その他） ・クリプトコッカス薬の北米市場：主要企業・種類別/用途別市場規模 ・クリプトコッカス薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Cryptococcosis is a fungal disease.It is caused by Cryptococcus neococcus, or Cryptococcus gattii.The disease is spread by inhaling a fungus linked to birds.It can infect animals and humans.It infects humans by inhaling fungus.The fungus mainly affects the lungs, but it can spread to the brain, called meningitis.Symptoms of the disease include - fever, headache, fatigue, dry cough and blurred vision.It can be treated by dozing off with amphotericin B, fluorocytosine and fluconazole.In 2018, the global Cryptococcosis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR...
  • 鼻ポリープ薬の世界市場：規模・現状・予測2019-2025
    DATA909X18738 / QYResearch / 2019年11月25日 / ※当調査レポートでは、鼻ポリープ薬の世界市場について調査・分析し、鼻ポリープ薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（コルチコステロイド、抗生物質、ロイコトリエン阻害剤、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の鼻ポリープ薬市場動向 ・主要企業別マーケットシェア ・鼻ポリープ薬の種類別市場規模2014-2019 （コルチコステロイド、抗生物質、ロイコトリエン阻害剤、その他） ・鼻ポリープ薬の用途別市場規模2014-2019 （病院、クリニック、その他） ・鼻ポリープ薬の北米市場：主要企業・種類別/用途別市場規模 ・鼻ポリープ薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occur in both nostrils in those who are affected. Complications may include sinusitis and broadening of the nose.In 2018, the global Nasal Polyps Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on...

    • ◆H&Iグローバルリサーチのお客様（例）◆